Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Steroids × Genitourinary × Clear all

Phase

Phase 3 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 3 Breast 2 Lymphoid 1 Head & Neck 1 Genitourinary 1 Gastrointestinal 1

Conditions

Prostatic Neoplasms 1

Interventions

Docetaxel 169 Prednisone 126 Gemcitabine 126 pembrolizumab 102 enzalutamide 100 Abiraterone Acetate 93 Nivolumab 87 Magnetic Resonance Spectroscopy 86 Cisplatin 86 Leuprolide 81 Radiotherapy 79 Sunitinib 77 Carboplatin 73 Specimen Handling 61 Radiosurgery 56 Paclitaxel 54 Goserelin 53 Androgen Antagonists 51 bicalutamide 49 Ipilimumab 49 apalutamide 47 Bevacizumab 44 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 43 Sorafenib 43 cabozantinib 41 Everolimus 41 cabazitaxel 40 abiraterone 39 atezolizumab 36 Axitinib 35

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04915508 2025-06-22

EXCALIBUR

Jonsson Comprehensive Cancer Center

Phase 2 Recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡